|
Overview
Pain is the most common chief
complaint in primary care, with chronic pain reported in 20%
of visits to primary care providers. Despite improved knowledge
and resources, unrelieved pain remains a major clinical problem.
Adverse consequences of under-treated pain are considerable.
Poorly managed acute pain may cause serious medical complications
such as pneumonia or deep venous thrombosis; impair recovery
from injury or procedures; and/or progress to chronic pain.
Under-treated chronic pain can impair an individual’s
ability to carry out daily activities and diminish quality
of life.
This interactive program will provide an update on the current
understanding of pain management (pharmacologic and non-pharmacologic),
with a particular focus on musculoskeletal pain and the use
of nonsteroidal anti-inflammatory agents. Conditions we will
review include osteoarthritis and rheumatoid arthritis; dysmenorrhea;
and post-surgical pain.
Learning Objectives
Upon completion of this course,
you should be able to:
-
Review the consequences of undertreatment
of pain
-
Discuss the role of cyclooxygenase (COX-2)
inhibitors in arthritis, dysmenorrhea, and postoperative
pain
-
Describe the use of nonpharmacologic therapies
in pain management
Target Audience
This CE activity is designed
designed for nurse practitioners as well as other healthcare
providers who are involved in the diagnosis and treatment
of patients with chronic pain.
Learner Participation to Earn Credit
Faculty Disclosures
 Allison
R. Edmonds, MS, APRN-BC [BioSketch]
Faculty Instructor, University of
South Florida College of Nursing; Clinical Nurse Practitioner
and Preceptor, University of South Florida Department of Family
Medicine, Tampa, Florida
Disclosure: No financial relationships with a commercial
party to disclose.
 Gregory
B. Holm, PhD, ARNP-C [BioSketch]
Assistant Professor, University of
South Florida Colleges of Medicine & Nursing, Tampa, Florida;
Practitioner, Lakeside Occupational Medical Centers, Pennsylvania
Disclosure: Speaker's Bureau: Pfizer.
|
